Vericel Corporation cash flow to debt ratio of 52.83% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Vericel Corporation's free cash flow has increased -525.88% from $-5.81M last year to $24.75M, signaling increasing performance

Vericel Corporation's debt to equity ratio is 0.25, which means that the company's assets are healthy financed, signaling financial stability.

Vericel Corporation's debt has decreased relative to shareholder equity from 0.34 last year to 0.25 today, signaling strengthened financials

Vericel Corporation has a net cash position, so leverage is healthy.

Vericel Corporation earns at least as much interest as it pays. Interest obligations are fully covered.

Vericel Corporation's profit margin has increased (81.03%) in the last year from 4.37% to 7.91%, signaling increasing performance

Vericel Corporation's short-term assets of $247.44M exceed its short-term liabilities of $49.15M

Vericel Corporation's return on assets of 4.82% is lower than the 5.00% threshold, indicating inefficient asset utilization

Vericel Corporation's return on equity of 6.91%, is lower than 15.00%, indicating bad performance

Vericel Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Vericel Corporation had positive net income in only 2 out of 5 years, indicating unstable earnings

Vericel Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Vericel Corporation has a free cash flow yield of 1.10%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Vericel Corporation's yearly earnings has increased 59.41% since last year from $10.36M to $16.52M, signaling increasing performance

Vericel Corporation's yearly revenue has increased 16.45% since last year from $237.22M to $276.26M, signaling increasing performance

ROIC 3.79% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Vericel Corporation's 3-year revenue CAGR of 18.90% is positive, indicating growing revenue over the past 3 years

Vericel Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Vericel Corporation had positive ROE in only 2 out of 5 years, indicating inconsistent returns on equity

Vericel Corporation is overvalued relative to its fair value price of 8.67 based on Discounted Cash Flow model

Vericel Corporation has an earnings yield of 1.08%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Vericel Corporation is overvalued relative to its fair value price of 4.20 based on EBITDA multiple model

Vericel Corporation has an EV/EBITDA ratio of 72.99x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Vericel Corporation is overvalued relative to its fair value price of -3.36 based on Earnings Fair Value model

Vericel Corporation has a PEG-ratio over 1 which is considered overvalued

Vericel Corporation has a price-to-book ratio of 6.05x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Vericel Corporation has a price-to-sales ratio of 7.31x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue